Peter G. Ulrich, has served as an executive in the health care and biotechnology industry for over 30 years, including 8 years at Baxter HealthCare where he held domestic and international marketing management positions. He has over 16 years experience in CEO or senior management capacities in the biotechnology industry with companies including NeuroVir Therapeutics, La Jolla Pharmaceutical Co. and TargeGen.

In conjunction with co-founding TargeGen Inc., Mr. Ulrich served as the first Entrepreneur in Residence for Forward Ventures and assumed the role of president & CEO of TargeGen, Inc. in March, 2002. TargeGen has attracted more than $110M in venture funding and is working on the development of four internally discovered drug candidates. TargeGen was named one of the top 100 venture backed companies in North America by Venture Reporter Magazine. TargeGen’s TG100-115 compound received the UCSD Connect “Most Innovative Product of the Year Award” in 2004. Mr Ulrich was the recipient of the 2006 Ernst & Young “Entrepreneur of the Year Award” in the emerging company category.

Mr. Ulrich received his B.A. from the University of Texas (Austin) and an M.S. in International Business Administration from the University of Dallas.